Asia- Pacific is a key driving force of the current global pharmaceutical industry. In recent years, healthcare demands among the region's growing populations have skyrocketed and its low operating costs continue to attract global pharmaceuticals to set up plants and offices in this region. Furthermore, it is emerging as a powerhouse for R&D, facilitated by the availability of a vast patient pool, quality data and skilled manpower.
The Asia-Pacific is the third largest pharmaceutical market in the world, behind North America and Europe, with many leading Asian pharmaceutical companies becoming successful due to their ability to retain their cost advantage.
Download the infographic here for a breakdown of domestic pharmaceutical market value for countries within Asia.
For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D